[ Ссылка ]
Dr. Louis Boon is Chief Scientific Officer of Bioceros, based in the Netherlands, a division of Poland’s Polpharma Biologics Group, a one-stop-shop CDMO offering novel technologies on their own platform generating high-yield GMP-ready protein producing cell lines. Speaking at BIO-Europe® 2019 in Hamburg, Dr. Boon cited two exciting recent partnerships, one with Sandoz for commercialization of a Natalizumab biosimilar, and just last week an agreement involving one of their microbial products with Coherus. Bioceros’ services are available on a modular basis, fully adjustable to clients’ requests, working together with the other divisions of the Polpharma Biologics Group to offer a completely integrated program from DNA to drug product.
